States / New Hampshire / SB 465
SB 465 Failed
classifying xylazine as a schedule III controlled drug.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Version comparison
2 versionsSign in to read the full text
The document summary and details above are public. The full text is available to signed-in accounts.